Additive preventive effect of influenza and pneumococcal vaccines in the elderly

References

• World Health Organization. Influenza vaccines. Wkly Epidemiol Rec 2005; 80(33): 279-87. Available: http://www.who.int/wer. Accessed: 01 October 2012.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057-62; http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5933a1.htm. Accessed 01October 2012;.PMID: 20798667
   PubMedGoogle Scholar
• Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al.; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56(RR-6):1-54; http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5606a1.htm. Accessed 01 October 2012;.PMID: 17625497
   PubMedGoogle Scholar
• Vaccination schedule for 2005. Recommendations from the “Conseil supérieur d’hygiène publique de France. BEH 2005; 29-30:142 - 56
   Google Scholar
• Lina B, Holm MV, Szucs TD. [Evolution of influenza vaccination coverage in France from 2001 to 2006]. Med Mal Infect 2008; 38:125 - 32; http://dx.doi.org/10.1016/j.medmal.2007.11.014; PMID: 18191520
   PubMed Web of Science ®Google Scholar
• Vaux S, Van Cauteren D, Guthmann JP, Le Strat Y, Vaillant V, de Valk H, et al. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health 2011; 11:30; http://dx.doi.org/10.1186/1471-2458-11-30; PMID: 21226919
   PubMed Web of Science ®Google Scholar
• Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Respir Crit Care Med 2005; 26:563 - 74; http://dx.doi.org/10.1055/s-2005-925523; PMID: 16388428
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global surveillance for severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003; 78(14):110-19. Available: http://www.who.int/wer. Accessed: 18 December 2011.
   Google Scholar
• Rosenheim M. Comité technique des vaccinations. Rapport. Efficacité du vaccin polysaccharidique pneumococcique chez les sujets âgés. 2002 [Article in French] Available: http://www.hcsp.fr/docspdf/cshpf/r_mt_021212_rapport.pdf. Accessed 01 October 2012.
   Google Scholar
• Assendelf WJ, Scholten RJPM, Offringa M. Pneumococcal vaccination for the elderly in The Netherlands? Assessment of the quality and content of available comparative studies. Neth J Med 2004; 62:36 - 44; PMID: 15127829
   PubMed Web of Science ®Google Scholar
• Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988; 108:653 - 7; PMID: 3358567
   PubMed Web of Science ®Google Scholar
• Farr BM, Johnston BL, Cobb DK, Fisch MJ, Germanson TP, Adal KA, et al. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch Intern Med 1995; 155:2336 - 40; http://dx.doi.org/10.1001/archinte.1995.00430210086013; PMID: 7487259
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, et al, EVAN Study Group. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006; 43:860 - 8; http://dx.doi.org/10.1086/507340; PMID: 16941367
   PubMed Web of Science ®Google Scholar
• Domínguez A, Izquierdo C, Salleras L, Ruiz L, Sousa D, Bayas JM, et al, Working Group for the Study of Prevention of CAP in the Elderly. Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Respir J 2010; 36:608 - 14; http://dx.doi.org/10.1183/09031936.00171309; PMID: 20075048
   PubMed Web of Science ®Google Scholar
• Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993; 270:1826 - 31; http://dx.doi.org/10.1001/jama.1993.03510150060030; PMID: 8411526
   PubMed Web of Science ®Google Scholar
• Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999; 159:2437 - 42; http://dx.doi.org/10.1001/archinte.159.20.2437; PMID: 10665892
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Turello V, Lai P, Bastone G, De Luca S, Rosselli R, et al. Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res 2005; 33:490 - 500; PMID: 16222881
   PubMed Web of Science ®Google Scholar
• Alfageme I, Vazquez R, Reyes N, Muñoz J, Fernández A, Hernandez M, et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 2006; 61:189 - 95; http://dx.doi.org/10.1136/thx.2005.043323; PMID: 16227328
   PubMed Web of Science ®Google Scholar
• Gaillat J, Zmirou D, Mallaret MR, Rouhan D, Bru JP, Stahl JP, et al. [Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions]. Rev Epidemiol Sante Publique 1985; 33:437 - 44; PMID: 3914014
   PubMed Web of Science ®Google Scholar
• Simberkoff MS, Cross AP, Al-Ibrahim M, Baltch AL, Geiseler PJ, Nadler J, et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 315:1318 - 27; http://dx.doi.org/10.1056/NEJM198611203152104; PMID: 3534568
   PubMed Web of Science ®Google Scholar
• Koivula I, Stén M, Leinonen M, Mäkelä PH. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med 1997; 103:281 - 90; http://dx.doi.org/10.1016/S0002-9343(97)00149-6; PMID: 9382120
   PubMed Web of Science ®Google Scholar
• Ortqvist A, Hedlund J, Burman LA, Elbel E, Höfer M, Leinonen M, et al, Swedish Pneumococcal Vaccination Study Group. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 1998; 351:399 - 403; http://dx.doi.org/10.1016/S0140-6736(97)07358-3; PMID: 9482293
   PubMed Web of Science ®Google Scholar
• Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010; 340:c1004; http://dx.doi.org/10.1136/bmj.c1004; PMID: 20211953
   PubMed Web of Science ®Google Scholar
• Dubois G. [Pneumococcal vaccination in France among adults]. Bull Acad Natl Med 2002; 186:1461 - 76, discussion 1476-7; PMID: 12669362
   PubMed Web of Science ®Google Scholar
• Risso K, Naqvi A, Pillet S, Leplatois A, Pulcini C. [Insufficient pneumococcal vaccine coverage in adult inpatients at risk]. Med Mal Infect 2010; 40:341 - 6; http://dx.doi.org/10.1016/j.medmal.2009.12.004; PMID: 20079590
   PubMed Web of Science ®Google Scholar
• Kuster SP, Tuite AR, Kwong JC, McGeer A, Fisman DN, Toronto Invasive Bacterial Diseases Network Investigators. Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance. PLoS Med 2011; 8:e1001042; http://dx.doi.org/10.1371/journal.pmed.1001042; PMID: 21687693
   PubMedGoogle Scholar
• Hedlund J, Christenson B, Lundbergh P, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 2003; 21:3906 - 11; http://dx.doi.org/10.1016/S0264-410X(03)00296-2; PMID: 12922125
   PubMed Web of Science ®Google Scholar
• Christenson B, Hedlund J, Lundbergh P, Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004; 23:363 - 8; http://dx.doi.org/10.1183/09031936.04.00063504; PMID: 15065822
   PubMed Web of Science ®Google Scholar
• Chang YC, Chou YJ, Liu JY, Yeh TF, Huang N. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan--a representative population-based comparative study. [Epub ahead of print] J Infect 2012; 65:231 - 8; http://dx.doi.org/10.1016/j.jinf.2012.04.014; PMID: 22561486
   PubMed Web of Science ®Google Scholar
• Gilchrist SA, Nanni A, Levine O. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. Am J Public Health 2012; 102:596 - 605; http://dx.doi.org/10.2105/AJPH.2011.300512; PMID: 22397339
   PubMed Web of Science ®Google Scholar
• Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 2008; 29:96 - 103; http://dx.doi.org/10.1093/eurheartj/ehm516; PMID: 18063596
   PubMed Web of Science ®Google Scholar
• Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127:1952 - 9; http://dx.doi.org/10.1378/chest.127.6.1952; PMID: 15947307
   PubMed Web of Science ®Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in 2005/2006-influenza season. Wkly Epidemiol Rec 2005; 80(8): 71-. Available: http://www.who.int/wer. Accessed: 01 October 2012.
   Google Scholar
• Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009; 58:446 - 58; http://dx.doi.org/10.1016/j.jinf.2009.04.001; PMID: 19446340
   PubMed Web of Science ®Google Scholar
• Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008; 8:272; http://dx.doi.org/10.1186/1471-2458-8-272; PMID: 18673545
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121:947 - 52; PMID: 7978721
   PubMed Web of Science ®Google Scholar
• Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. [Erratum in: JAMA 1994; 271] [20] JAMA 1993; 270:1956 - 61; http://dx.doi.org/10.1001/jama.1993.03510160074032; PMID: 8411553
   PubMed Web of Science ®Google Scholar
• Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778 - 84; http://dx.doi.org/10.1056/NEJM199409223311206; PMID: 8065407
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518 - 27; PMID: 7661497
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366:1165 - 74; http://dx.doi.org/10.1016/S0140-6736(05)67339-4; PMID: 16198765
   PubMed Web of Science ®Google Scholar